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Abstract
Surfactant proteins B and C (SP-B and SP-C) are present in natural derived surfactant preparations used for treatment of
respiratory distress syndrome. Herein the surface activity of an SP-C analogue (SP-C(LKS)), a hybrid peptide between SP-C
and bacteriorhodopsin (SP-C/BR) and a model peptide (KL4) was studied with a captive bubble surfactometer (CBS). The
peptides were mixed with either 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)/phosphatidylglycerol (PG) (7:3, by
weight) or DPPC/PG/palmitic acid (68:22:9, by weight) at a concentration of 1 mg/ml in HEPES buffer, pH 6.9 and a
polypeptide/lipid weight ratio of 0.02^0.03. In some lipid/peptide preparations also 2% of SP-B was included. Adsorption,
monitored as surface tension vs. time for 10 min after bubble formation did not show discernible differences for the whole set
of preparations. Equilibrium surface tensions of approximately 25 mN/m were reached after 5^10 min for all preparations,
although those with SP-C/BR appeared not to reach end point of adsorption within 10 min. Area compression needed to
reach minimum surface tension of 0.5^2.0 mN/m was least for the KL4 preparation, about 13% in the first cycle. 3% SP-
C(LKS) in DPPC:PG (7:3, by weight) reached minimum surface tension upon 27% compression in the first cycle. If
DPPC:PG:PA (68:22:9, by weight) was used instead only 16% area compression was needed and 14% if also 2% SP-B was
included. 3% SP-C(LKS) in DPPC:PG (7:3, by weight)+2% SP-B needed 34% compression to reach minimum surface
tension. The replenishment of material from a surface associated surfactant reservoir was estimated with subphase depletion
experiments. With the 2% KL4 preparation incorporation of excess material took place at a surface tension of 25^35 mN/m
during stepwise bubble expansion and excess material equivalent to 4.3 monolayers was found. When 2% SP-B was added to
3% SP-C(LKS) in DPPC:PG (7:3, by weight) the number of excess monolayers increased from 1.5 to 3.6 and the
incorporation took place at 30^40 mN/m. When SP-B was added to 3% SP-C(LKS) in DPPC:PG:PA (68:22:9, by weight)
the number of excess monolayers increased from 0.5 to 3.4 and incorporation took place at 40^50 mN/m. With 2% SP-C/BR
incorporation took place at 40^45 mN/m, frequent instability clicks were observed and excess material of approximately 1.1
monolayer was estimated. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Pulmonary surfactant is a complex material syn-
thesised and excreted by alveolar type II cells. The
main constituents are phosphatidylcholine, especially
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)
and phosphatidylglycerol (PG). A minor but essen-
tial part of surfactant are the proteins. The hydro-
phobic surfactant proteins B and C (SP-B and SP-C)
are probably both involved in the alveolar air/liquid
surface ¢lm formation. The hydrophilic surfactant
proteins SP-A and SP-D are C-type (Ca2-depen-
dent) collagenous lectins and are thought to act pri-
marily in the host-defence system. SP-A and SP-D do
however also interact with lipids in vitro. SP-A
causes lipid aggregation in the presence of Ca2
and is essential for the tubular myelin formation in
vivo [1]. Lipids accumulate in the lungs of SP-D
knock out mice, which suggests a role of SP-D in
the metabolism of surfactant lipids [2,3].
Decreased levels of surfactant in premature babies
result in respiratory distress syndrome (RDS) and is
treated with exogenous surfactant isolated from ani-
mal tissue by extraction with organic solvents. These
preparations contain, apart from the phospholipids,
1^2% (by weight) SP-B and SP-C [4,5]. The polypep-
tides improve surface activity dramatically compared
to pure lipid preparations [6].
The primary and secondary structures of SP-B and
SP-C and a tertiary structure of SP-C in solution
have been determined [5,7,8]. SP-B is a dimeric mol-
ecule composed of two identical polypeptide chains
of 79 amino acids with an interchain disulphide
bridge and may interact with two lipid bilayers and
bring them into close proximity [5,9]. This has been
supported experimentally in several studies [10^13].
It has been shown in vivo that homozygous SP-B
de¢cient mice can not expand their lungs and die
within minutes of birth [14]. SP-C is a lipoprotein
composed of 35 amino acid residues with an K-heli-
cal domain between residues 9^34 [8]. The helix is
composed mostly of valyl residues and is embedded
in a lipid bilayer and oriented in parallel with the
lipid acyl chains [5,8]. SP-C is thought to in£uence
the thickness and £uidity of the surrounding lipid
layers via the extremely stable poly-valyl helix [5].
Two palmitoyl groups are covalently linked to cys-
teine residues in positions 5 and 6 in the N-terminal
part of the peptide. Surface activity in vitro of chemi-
cally deacylated SP-C [15^17] indicates that palmi-
toylation is essential for good adsorption, mechanical
stability and reformation of surfactant ¢lm at the
interface as well as low ¢lm compressibility. With
SP-C(Leu), an SP-C analogue where the poly-valyl
helix has been replaced with poly-leucyl residues in
order to avoid aggregation [18], improvements in
surface activity are observed after palmitoylation.
Most pronounced is the increased mechanical stabil-
ity and improved incorporation of surfactant materi-
al from the surface associated reservoir [19].
Although the di¡erent components of pulmonary
surfactant have been largely characterised the inter-
action mechanism at the molecular level is not fully
understood. Synthetic polypeptide analogues of the
surfactant proteins or their fragments can be used as
tools to further approach this issue. In the present
study we have investigated the surface activity of
three synthetic polypeptides combined with lipid
mixtures or lipid mixtures and native porcine SP-B.
SP-C(LKS) is a polyleucine SP-C analogue (Table 1)
where three leucines have been replaced with lysine
residues in order to locate positive charges around
the helical circumference. This makes it easy to han-
dle and self-polymerisation is avoided [20]. SP-C/BR
is a hybrid peptide (Table 1) where positions 13^35
of SP-C have been replaced with the amino acid
sequence of positions 42^64 of bacteriorhodopsin,
which is a known transmembrane K-helix [21].
Table 1
Amino acid sequence of SP-C and the polypeptides investigated
1 10 20 30
Human SP-C F G I P C C P V H L K R L L I V V V V V V L I V V V I V G A L L M G L
SP-C(LKS) - - - - S S - - - - - - - - - L K L L L L K - L L L K L - - - - - - -
SP-C/BR - - - - - - - - - - - - F Y A I T T L V A A I A F T L Y L S L L L G Y
KL4 K L L L L K L L L L K L L L L K L L L L K
Bars indicate residues identical with those in human SP-C.
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Finally, KL4 (Table 1) which has been designed from
the N-terminal part of SP-B [22] was included. In the
present study, adsorption, ¢lm compression needed
to achieve minimum surface tension, maximum sur-
face tension and stability upon dynamic cycling as
well as the existence of excess surface associated ma-
terial have been investigated in the captive bubble
surfactometer (CBS).
2. Materials and methods
2.1. Peptide synthesis, puri¢cation and
characterisation
Two analogues of SP-C, SP-C(LKS) [20] and SP-
C/BR [21] as well as the SP-B model peptide KL4
[22] (Table 1) were synthesised by use of stepwise
solid phase technology and the tert-butyloxycarbonyl
(t-BOC) chemistry in an Applied Biosystems 430A
instrument. Reagents and t-BOC amino acids for
peptide synthesis were from Perkin-Elmer. Cleavage
of the resin^peptide bond and deprotection of the
side-chains were carried out in anhydrous hydrogen
£uoride/metoxybenzene/dimethylsul¢de,10:1:1 (v/v/v)
for 1.5 h at 0‡C. Protecting groups and scavengers
were removed by repeated extractions with diethyl
ether. The peptides were extracted from the resin
with dichloromethane/tri£uoroacetic acid (TFA) 3:1
(v/v) or with 40% (v/v) acetic acid for SP-C/BR, fol-
lowed by rotary evaporation. The crude peptide ex-
tracts of KL4 and of SP-C/BR were dissolved in
ethanol and puri¢ed with reversed phase HPLC us-
ing a C18 column (Vydak 2.2U250 mm) and a linear
gradient of 60% aqueous methanol/0.1% TFA and
isopropanol/0.1% TFA over 40 min with a £ow
rate of 0.7 ml/min [23]. SP-C(LKS) was puri¢ed
with exclusion chromatography on Sephadex LH-60
in chloroform/methanol 1:1 (v/v) containing 5%
H2O. An aliquot of 10 mg at a concentration of
approximately 100 mg/ml was applied on a Sephadex
LH-60 column (40U1 cm) and eluted with a £ow
rate of 6^8 ml/min [20]. SP-B was obtained from
porcine lungs as described previously [6]. Identi¢ca-
tion and quanti¢cation were made by amino acid
analysis with an LKB Alpha Plus analyser.
Molecular masses were determined by matrix-as-
sisted laser desorption ionisation-time of £ight
(MALDI-TOF) mass spectrometry (Lasermat 2000,
Finnigan MAT) calibrated with vasoactive intestinal
peptide ([M+H] 3326.8) or with porcine insulin
([M+H] 5778.6).
2.2. Preparation of peptide/lipid mixtures
DPPC, PG and palmitic acid (PA) were purchased
from Sigma Chemical Co. (St Louis, MO, USA). The
lipids, dissolved in chloroform/methanol 98:2 (v/v),
were mixed in the proportions DPPC:PG:PA
68:22:9 (w/w/w) or DPPC:PG 7:3 (w/w). Surfactant
preparations were prepared by adding SP-C(LKS)
alone or SP-C(LKS) and SP-B in each of the lipid
mixtures at a total polypeptide/lipid ratio of 0.02^
0.05, by weight as previously evaluated [20]. KL4
alone or SP-C/BR alone were added to the
DPPC:PG:PA mixture at polypeptide/lipid weight
ratios of 0.02 in accordance with earlier studies
[18]. The mixtures were evaporated under nitrogen
and suspended at room temperature in 10 mmol/l
HEPES bu¡er pH 6.9 containing 140 mmol/l NaCl
and 2.0 mmol/l CaCl2, at a lipid concentration of
1 mg/ml.
2.3. Surface activity measurements
A captive bubble surfactometer [24] was used to
determine the area, volume and surface tension of a
surfactant ¢lm at the bubble air^water interface. The
bubble shape was monitored using a video system,
digitised and used to calculate surface tension and
area of captive air bubbles [25]. Measurements were
made during lipid adsorption and compression and
expansion of a bubble under quasi-static or dynamic
conditions. After substituting the surfactant in the
subphase by normal saline (depletion experiments)
quasi-static cycles were conducted.
2.3.1. Adsorption studies
An atmospheric bubble of 6^7 mm in diameter
was injected into the well-stirred surfactant suspen-
sion of the sample chamber. Time zero for adsorp-
tion was taken, when the bubble showed a Laplacian
shape, which occurred within 0.15 s. The bubble was
then left undisturbed for 10 min. Adsorption was
completed when a surface tension of 23^25 mN/m
was reached.
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2.3.2. Quasi-static cycles
After adsorption the bubble was stepwise com-
pressed with a 2^3 s delay after each step until fur-
ther compression did not a¡ect bubble height, indi-
cating that minimum surface tension was reached.
Subsequently the bubble was expanded in the same
manner until the original volume was reached (for
details see [26]). The cycle was repeated four times,
after 2 min inter-cycle delay. Each peptide/lipid prep-
aration was examined in triplicate. The average sur-
face tension calculated after each step of cycles 1 and
4 were plotted against the relative bubble area. The
area measured after adsorption with the equilibrium
surface tension of 23^25 mN/m was set to 1.0.
2.3.3. Dynamic cycles
After adsorption as above the bubble was com-
pressed and expanded continuously for 20 cycles at
a rate of 20^30 cycles/min. Compression was not
terminated when minimum surface tension was
reached, instead the bubble was overcompressed by
approximately 20%. By overcompressing the bubble
at minimum surface tension a collapse phase is
formed, which might remain associated with the in-
terface or might be lost to the surrounding subphase
[27].
2.3.4. Subphase depletion
After bubble adsorption as above the surfactant
preparation was washed out and substituted with
0.15 mol/l NaCl, 1.5 mmol/l CaCl2. 3^5 quasi-static
cycles were then performed. After compression to
minimum surface tension in the ¢rst cycle the bubble
was expanded to its original size and allowed to rest
for 2 min, followed by stepwise expansions of the
diameter of approximately 0.5 mm at each step.
After each step there was a 2 min waiting period
during which the bubble shape £attened, indicating
a decrease in surface tension due to adsorption of
material from a surface associated surfactant reser-
voir [28]. After 3^4 adsorption steps with a 2 min
delay in between the second cycle was started by
compressing the bubble to minimum surface tension.
Stepwise expansion was repeated 3^4 times after each
cycle until no adsorption took place during the 2 min
delay and surface tension rose rapidly on bubble ex-
pansion. From these manipulations the adsorption
from the surface associated reservoir was estimated.
Since there was no surfactant in the surrounding
subphase the decrease in surface tension after each
expansion was due to the material in excess of the
interfacial monolayer. The bubble area at minimum
surface tension of the ¢rst cycle was compared to
that of the ¢nal cycle and the amount of excess ma-
terial is expressed as number of monolayers.
2.4. Statistical analysis
Where applicable, data points in the graphs repre-
sent means þ S.E.M., n = 3. Multiple mean compari-




After bubble formation had taken place the
preparations containing 3% SP-C(LKS)+2% SP-B re-
quired 5 min to reach a surface tension of 25 mN/m.
The surface tensions reached by adsorption at each
time interval appeared to be slightly higher without
SP-B, but the di¡erences were not discernible at the
0.05% level (Fig. 1). The presence of PA did not
in£uence the adsorption rate, neither in the presence
nor in the absence of 2% SP-B in the preparations
with 3% SP-C(LKS).
In the preparation with 2% KL4 the surface ten-
sion was around 35 mN/m at time zero and adsorp-
tion was completed in 6 min, while 2% SP-C/BR did
not reach end point of adsorption (25 mN/m) within
10 min (data not shown). However, no signi¢cant
di¡erences were found in the surface tensions
reached on adsorption at each time interval when
all samples were considered.
3.2. Quasi-static cycles
Film area compression needed to compress the
surfactant ¢lms in a quasi-static manner from equi-
librium surface tension of approximately 25 mN/m to
a minimum surface tension of 0.5^2.0 mN/m was
determined for the di¡erent surfactant preparations.
The preparation with 3% SP-C(LKS) in DPPC:PG
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7:3 (w/w) needed an area compression of approxi-
mately 27% to reach a minimum surface tension of
1 mN/m in the ¢rst cycle, with only a slight improve-
ment in the fourth cycle. With PA in the lipid mix-
ture, the area compression needed to reach minimum
surface tension decreased to about 16% (Fig. 2A).
When both 3% SP-C(LKS) and 2% SP-B were
present in DPPC:PG 7:3 (w/w), but without PA, al-
most 30% area compression was needed in the ¢rst
cycle and 20% in the fourth. For the preparation
with 3% SP-C(LKS) and 2% SP-B in DPPC:PG:PA
68:22:9 (w/w/w) only 14% area compression was
needed (Fig. 2B). The 2% KL4 preparation needed
an area compression of about 13% in the ¢rst cycle
with some improvement by the fourth cycle, while
the 2% SP-C/BR surfactant improved from 30 to
24% from the ¢rst to the fourth cycle (Fig. 3), but
the change was not statistically discernible
(Ps 0.05).
In summary: (1) Films from all preparations could
be compressed quasi-statically to obtain minimum
surface tensions below 2 mN/m. (2) Films formed
from the 2% KL4 preparations required area com-
pressions of about 13% to achieve minimum surface
tensions of approximately 1 mN/m, similar to those
needed for the ¢lms with 3% SP-C(LKS)+2% SP-B
in the presence of PA. Films from the 2% SP-C/BR
preparations required relatively large ¢lm area com-
pressions (V30%) to reach minimum surface ten-
sion, similar to those needed for the preparations
with 3% SP-C(LKS)+2% SP-B, without PA. These
area compressions were signi¢cantly larger than
those for the preparations with 3% SP-C(LKS)+2%
SP-B with PA.
3.3. Dynamic cycles
All samples exhibited a minimum surface tension
below 1 mN/m upon continuous cycling at a rate of
20^30 cycles/min. The preparation with 3% SP-
Fig. 1. Time course for adsorption of SP-C(LKS) in DPPC/PG/
PA (68:22:9, by weight) with and without SP-B. Surface ten-
sion is plotted vs. time. Open circles, 3% SP-C(LKS); and ¢lled
circles, 3% SP-C(LKS)+2% SP-B.
Fig. 2. (A) Quasi-static compression isotherms of SP-C(LKS) in
lipid mixtures with and without PA. Surface tension is plotted
vs. relative area for the ¢rst cycles. Open circles, 3% SP-
C(LKS) in DPPC/PG/PA (68:22:9, by weight); open triangles,
3% SP-C(LKS) in DPPC:PG (7:3, by weight). (B) Quasi-static
compression isotherms of SP-C(LKS)+SP-B in lipid mixtures
with and without PA. Surface tension is plotted vs. relative
area for the ¢rst (open symbols) and fourth (¢lled symbols)
cycles. Circles, 3% SP-C(LKS)+2% SP-B in DPPC/PG/PA
(68:22:9, by weight) ; triangles, 3% SP-C(LKS)+2% SP-B in
DPPC:PG (7:3, by weight).
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C(LKS) in DPPC:PG 7:3 (w/w) showed a maximum
surface tension of 48^49 mN/m, similar to the max-
imum surface tension (50^51 mN/m) of the same
preparation with PA. The addition of 2% SP-B to
the preparations with 3% SP-C(LKS) þ PA reduced
the maximum surface tension slightly to 46^47 mN/m,
but these values were not discernible from those
without SP-B (Ps 0.05). In Fig. 4, cycles from prep-
arations with 3% SP-C(LKS) and PA þ 2% SP-B are
shown. The 2% KL4 preparation showed a maximum
surface tension of 44^45 mN/m and a region of high
compressibility around 20 mN/m. 2% SP-C/BR
showed a maximum surface tension of 50^51 mN/m,
and at minimum surface tension sudden drops in
bubble area combined with increments in surface ten-
sion, consistent with bubble clicks, were observed
(Fig. 5).
The total ¢lm area compressions were 50^60%,
including the reduction in ¢lm area at near zero min-
imum surface tension, as seen in the horizontal part
of the dynamic curves (Figs. 4, 5, 6). The ¢lms from
the 2% KL4 preparations reduced the surface tension
to below 1 mN/m upon an area reduction of only
18%, which is signi¢cantly lower than for all the
other preparations (P6 0.01) (Fig. 5). The ¢lms
from SP-C/BR and those from the 3% SP-
C(LKS) þ SP-B but without PA required the highest
¢lm area reductions to reach minimum surface ten-
sion (34^38%). Adding PA to the above SP-C(LKS)
preparations reduced the ¢lm area compressions to
approximately 30% (P6 0.01) (Fig. 6).
3.4. Subphase depletion
In the preparations with 3% SP-C(LKS) in
DPPC:PG 7:3 (w/w) without PA, incorporation
of surface associated reservoir material occurred at
Fig. 3. Quasi-static compression isoterms of 2% SP-C/BR and
2% KL4 in DPPC:PG:PA (68:22:9, by weight). Surface tension
is plotted vs. relative area for the ¢rst (open symbols) and
fourth (¢lled symbols) cycles. Circles, 2% SP-C/BR; triangles,
2% KL4.
Fig. 4. Dynamic (20^30 cycles/min with approximately 20%
overcompression) surface tension^area relationships of 3% SP-
C(LKS) in DPPC/PG/PA (68:22:9, by weight) with and without
2% SP-B. Three consecutive dynamic cycles centred at cycle 10
are shown. Open circles, 3% SP-C(LKS); ¢lled circles, 3% SP-
C(LKS)+2% SP-B.
Fig. 5. Dynamic (20^30 cycles/min with 20% overcompression)
surface tension^area relationships of 2% SP-C/BR and 2% KL4
in DPPC:PG:PA (68:22:9, by weight). Three consecutive dy-
namic cycles centred at cycle 10 are shown. Filled circles, 2%
KL4 ; open circles, 2% SP-C/BR.
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30^40 mN/m during stepwise bubble expansion. Min-
imum surface tension below 1 mN/m was reached in
all cycles (Fig. 7A). Area compression needed to
reach near zero minimum surface tension was around
30% in all cycles. No squeeze out plateaus were ob-
served during compression, although sudden surface
tension increases with associated drops in surface
area (consistent with clicks) at minimum surface ten-
sion were observed. A surface associated reservoir
equivalent to 1.5 monolayers in excess of one mono-
layer was calculated.
In contrast when 3% SP-C(LKS) was combined
with the lipid mixture DPPC:PG:PA surface activity
deteriorated (Fig. 7B). Incorporation of surface asso-
ciated reservoir material occurred at 40^50 mN/m
during stepwise bubble expansions. Minimum sur-
face tension increased upon cycling from 2 mN/m
in the ¢rst cycle to 5 mN/m in the third cycle, and
area compression needed to reach 5 mN/m was 45%.
There was a region of high ¢lm compressibility
(squeeze out plateau) at about 20 mN/m on the third
compression and clicks at minimum surface tension
were observed. There was only material of 0.5 mono-
layers in excess of one monolayer associated with the
surface ¢lm.
In the depletion studies with 3% SP-C(LKS)+2%
SP-B in DPPC:PG 7:3 (w/w), without PA, incorpo-
ration of surface associated reservoir material oc-
curred at 30^40 mN/m during stepwise bubble ex-
pansion (Fig. 8A). A minimum surface tension of
zero was reached in all cycles and the area compres-
sion needed to reach zero minimum surface tension
was 22% in the ¢rst cycle and 24% in the ¢fth. No
squeeze out plateaus were observed during compres-
sion and clicks did not occur. 3.6 monolayers of ex-
cess material were calculated.
With 3% SP-C(LKS)+2% SP-B but using
DPPC:PG:PA 68:22:9 (w/w/w) as the lipid mixture
the adsorption upon stepwise increase of the bubble
size occurred at the somewhat higher surface tension
Fig. 7. Series of consecutive quasi-static compression expansion
cycles conducted at increasing bubble areas, after surfactant de-
pletion and replacement of subphase with bu¡er (initial bubble
formation in 1 mg/ml surfactant). The plot represents consecu-
tive quasi-static cycles, starting with the ¢rst cycle at the left.
(A) 3% SP-C(LKS) in DPPC:PG (7:3, by weight). (B) 3%
SP-C(LKS) in DPPC/PG/PA (68:22:9, by weight).
Fig. 6. Dynamic (20^30 cycles/min with approximately 20%
overcompression) surface tension^area relationships of 3% SP-
C(LKS)+2% SP-B in lipid mixtures with and without PA.
Three consecutive dynamic cycles centred at cycle 10 are shown.
Filled circles, 3% SP-C(LKS)+2% SP-B in DPPC:PG (7:3, by
weight) ; open circles, 3% SP-C(LKS)+2% SP-B in DPPC/PG/
PA (68:22:9, by weight).
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around 40^50 mN/m (Fig. 8B) than when PA was
absent. Minimum surface tensions around zero were
reached after surface area compressions of 15% for
the ¢rst cycle and 35% for the ¢fth. No squeeze out
plateaus were observed during compression and sud-
den increase in surface tension at minimum surface
tension did not occur. Excess material equivalent to
3.4 monolayers were calculated.
The 2% KL4 preparation in DPPC:PG:PA
68:22:9 (w/w/w) incorporated material from surface
associated reservoir at 25^35 mN/m during stepwise
bubble expansion. Near zero surface tension was
reached in all cycles with a surface area compression
around 30% throughout the experiment. Squeeze out
plateaus were observed during compression in the
fourth and ¢fth cycle and small instability clicks
were observed at end compression for each cycle.
4.3 monolayers in excess of one monolayer were cal-
culated (Fig. 9A).
With 2% SP-C/BR in the same lipids the surface
tension for adsorption upon stepwise bubble expan-
sion was 40^45 mN/m and the area compression
needed was 43% in the ¢rst cycle and 32% in the
third. Instability clicks were observed as well as
high compressibility regions on compression at ap-
proximately 20 mN/m. Approximately one mono-
layer excess material in the surface associated reser-
voir was calculated (Fig. 9B).
Fig. 9. Series of consecutive quasi-static compression expansion
cycles after surfactant depletion and replacement of subphase
with bu¡er as in Fig. 7. (A) 2% KL4 in DPPC:PG:PA
(68:22:9, by weight). (B) 2% SP-C/BR in DPPC:PG:PA
(68:22:9, by weight).
Fig. 8. Series of consecutive quasi-static compression expansion
cycles after surfactant depletion and replacement of subphase
with bu¡er as in Fig. 7. (A) 3% SP-C(LKS)+2% SP-B in
DPPC:PG (7:3, by weight). (B) 3% SP-C(LKS)+2% SP-B in
DPPC/PG/PA (68:22:9, by weight).
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4. Discussion
There is no consensus theory established for the
mechanisms of interaction between the surfactant
proteins and lipids. SP-B has been shown to induce
lipid vesicle mixing, especially in the presence of PG
[29], probably by cross-linking lipid membranes by
means of ionic interactions. In that way SP-B could
maintain a surfactant reservoir close to the air^water
interface. It has been suggested that the biological
activity of SP-C is to enhance surfactant spreading,
and that this is an e¡ect of the K-helical conforma-
tion of the peptide rather than of the amino acid
sequence [21] (for de¢nitions of adsorption and
spreading see [30]). Although present in a monolayer
both SP-B and SP-C are able to promote insertion of
phospholipid molecules to the interface [31,32]. SP-
C/BR was designed as a representative K-helical
transmembrane peptide, and showed in mixtures
with lipids rapid spreading on a Wilhelmy balance
[21]. It has been stated that preparations with quick
adsorption, that is, rapid accumulation also exhibit
rapid spreading [30]. In the CBS spreading activity is
not studied per se but adsorption is monitored by
measuring the reduction in surface tension with
time. The surface activity of the SP-C/BR prepara-
tion was inferior to other peptide/lipid mixtures
studied. The preparation did not completely adsorb
during 10 min, exhibited clicks indicating instability
upon dynamic cycling, and showed a limited reser-
voir of excess surfactant material, or limited incor-
poration into the surface active ¢lm of such material.
One explanation could be the less hydrophobic char-
acter of the bacteriorhodopsin K-helix compared to
that of native SP-C or its analogues (Table 1).
We have studied the e¡ect of the addition of PA
to the SP-C(LKS) lipid mixture. PA is often added
to arti¢cial surfactant preparations and it often
increases the adsorption rate in the pulsating bubble
surfactometer (PBS) (unpublished observations) and
makes the suspensions more homogeneous. In the
CBS, no e¡ect of PA on adsorption was noted. How-
ever, addition of PA to the lipid mixture decreased
the ¢lm area compression needed to reach minimum
surface tension during quasi-static and dynamic
cycling (Figs. 2, 6). This is in agreement with
earlier ¢ndings [33]. On the other hand, PA seems
to reduce the amount of surface associated material
or its incorporation into the surface active ¢lm (Fig.
7).
The e¡ect of adding SP-B to SP-C(LKS) in lipid
mixtures with and without PA was studied. Addition
of SP-B increased the adsorption rate slightly, but
the increase was not discernible from that observed
on the preparations without SP-B, and the adsorp-
tion was not comparable to that of natural surfactant
preparations. Earlier studies using the PBS [20] have
demonstrated a decrease of surface tension at max-
imum bubble radius (Qmax) upon the addition of SP-
B, which was interpreted as an indication of SP-B
maintaining a surfactant reservoir. In the CBS, the
decrease of maximum surface tension upon dynamic
cycling after addition of SP-B (Fig. 4) was not as
pronounced as in the PBS [20] were it decreased
from 42 to 33^35 mN/m. The di¡erent results might
be related to the higher surfactant concentrations
used in the PBS, V10 mg/ml, vs. 1.0 mg/ml in the
CBS. It has been shown in earlier studies [27] that
maximum surface tension upon dynamic cycling is
dependent on the degree of compression. In the
present study, the ¢lms were compressed dynamically
to a total area compression of 50^60%, which might
be higher than the real ¢lm area compression in the
PBS, which nominally should be 50% but might be
lower due to ¢lm spreading in the capillary tube in
the device [34]. Relatively high ¢lm area compres-
sions upon dynamic cycling reduce ¢lm reformation
upon bubble expansion, causing higher maximum
surface tension and larger ¢lm area compressions
needed to achieve near zero surface tension com-
pared to ¢lms cycled with less area compressions
[35].
Both SP-B and SP-C promote lipid adsorption and
spreading at an air^water interface, but SP-C ap-
pears to be more e⁄cient than SP-B [5]. SP-B seems
to promote lipid insertion more e⁄ciently from sur-
face associated vesicles or multilamellar structures
than SP-C [36]. SP-B seems to be involved both in
the formation of the surface associated reservoir by
promoting bilayer^bilayer or bilayer^monolayer con-
tact [10^13] and to replenish the interface upon ex-
pansion [37]. The most pure experiment for studying
replenishment from the surface associated surfactant
reservoir is subphase depletion experiments. When
2% SP-B was added to the mixture of 3% SP-
C(LKS) in DPPC:PG 7:3 (w/w), the number of
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monolayers in excess of one monolayer increased
from 1.5 to 3.6. When 2% SP-B was present in the
mixture of 3% SP-C(LKS) in DPPC:PG:PA 68:22:9
(w/w/w) the number of calculated monolayers in ex-
cess of one monolayer increased from 0.5 to 3.4, but
incorporation of surface active material occurred at
somewhat higher surface tension. The KL4 prepara-
tion exhibited excess material of 4.3 monolayers and
thus mimics the action of SP-B under these condi-
tions. Interestingly this was not observed in the PBS,
where no decrease of Qmax was seen when KL4 was
added to the preparation of 3% SP-C(LKS) in
DPPC:PG 7:3 (w/w) [20]. However, in the PBS, ef-
fects due to phenomena related to the bulk suspen-
sion are not clearly separated from those related to
the surface associated material. In this investigation
the KL4 peptide was superior or equal to the best
combination of SP-C(LKS) and SP-B in the di¡erent
experimental protocols. Under dynamic conditions
KL4 surfactant seems to produce a monolayer en-
riched in DPPC which is continuously puri¢ed by
squeeze out at a surface tension of approximately
20 mN/m.
There are no generally accepted parameters for in
vitro evaluation of arti¢cial surfactant preparations.
Di¡erent preparations have been optimised individu-
ally, using di¡erent in vitro methods. Furthermore,
many in vitro methods only measure a speci¢c aspect
of surfactant activity. The CBS o¡ers a broad ap-
proach in optimising the preparations and a possibil-
ity to ¢nd a combination for which results from in
vitro studies better correlate with those from in vivo
animal models.
In summary, the adsorption rates were slow for all
samples compared to animal derived natural surfac-
tant preparations and were not signi¢cantly in£u-
enced by the inclusion of either PA or SP-B. In the
quasi-static experiments addition of PA, especially in
combination with SP-B, to SP-C(LKS)/DPPC/PG
decreased the compression needed to reach minimum
surface tension. Dynamic compression of KL4 con-
taining ¢lms were less e¡ected by overcompression
than those containing SP-C(LKS) and SP-B. After
subphase depletion SP-B containing preparations in-
creased the ability of the ¢lm to incorporate surfac-
tant material from the surface associated reservoir.
Also surface ¢lms of KL4 preparations had similar
properties and seem to act in an SP-B manner under
these conditions.
Recently di¡erent arti¢cial, synthetic peptide con-
taining, surfactant preparations have been found use-
ful for replacement therapy in experimental models
and clinically, i.e. KL4 surfactant [38,39] and rSP-C
surfactant [40]. The performance of an arti¢cial sur-
factant is however dependent on a PEEP (positive
end expiratory pressure) value [41]. In treatments
with natural surfactant preparations there is no
need for ventilation with PEEP to prevent the lungs
from collapse at end expiration. This indicates that
further improvements can be made. Improvement of
in vitro surface activity upon addition of SP-B has
been shown [20]. There is not yet reported a recombi-
nant expression of SP-B, nor does it appear possible
to synthesise large quantities of SP-B due to its size
and complexity. Absence of SP-B is fatal in the neo-
natal period [42] which has been con¢rmed in knock
out mice [14]. Since SP-B is needed for survival, its
signi¢cance is high. Addition of SP-B or a function-
ally related analogue that has the same ability of
keeping lipid bilayers in close proximity can improve
in vitro surface activity [9]. This might be a way to
¢nd more e⁄cient arti¢cial surfactant preparations
for replacement therapy.
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